Emergent BioSolutions (NYSE:EBS) said the U.S. Food and Drug Administration has approved a supplemental New Drug Application ...

Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be cleared from shelves as the FDA has proposed to discontinue the sale of products ...

Dr Reddy's Laboratories launched a generic OTC ophthalmic solution in the US for relieving itchy eyes, approved by the FDA.

A common cold medicine has been deemed ineffective and will no longer be available for purchase. The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a ...

The FDA orders the recall of a nasal spray in the US after finding live microbes; immunocompromised patients are at greatest ...

The FDA committee unanimously concluded the data do not support oral phenylephrine’s effectiveness as a nasal decongestant. The Food and Drug Administration (FDA) announced a proposal to remove oral ...

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After ...

Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.

For a second year, members of the Senate Health Committee advanced a bill Thursday to allow pharmacists to sell ivermectin, a ...

PHILADELPHIA, January 07, 2026--iECURE Receives FDA Regenerative Medicine Advanced Therapy Designation for ECUR-506 for ...